Offering RecordLongevity Biotech

BioXgen Holdings, Inc.

Captured Aug 24, 2026
Offering amount

$5,000,000

Carried interest

—

Structure

Spv

Minimum

—

Summary

BioXgen Holdings, Inc. is a $5,000,000 offering structured as a special purpose vehicle listed on DealMaker.

The securities are offered under Regulation CF.

Terms shown here are drawn from SEC filings and were captured by AltStreet on 2026-08-24. Figures are as disclosed at the time of the offering and are not updated for subsequent performance.

Disclosed Terms

Offering amount
$5,000,000
Structure
Spv
Status
Funding closed
Exemption
Regulation CF
Launched
2026-01-14
Closed
2026-05-15

Terms as disclosed at the time of the offering. AltStreet does not update these figures for subsequent performance, and a disclosed rate is not a realized return.

Filing Record

The issuer behind BioXgen Holdings, Inc. files under Regulation Crowdfunding (Form C). Its offering chain runs from C on Jan 14, 2026 to C-U on Oct 15, 2026, 5 filings in all. The latest filing reports $72,395 sold of a $1.2M offering. AltStreet's status rule reads the chain as target met (progress update reports an amount at or above the target).

  • 2026-10-15Progress update filedC-U$72,395
  • 2026-04-30Form C amendedC/A$1.2M
  • 2026-02-10Progress update filedC-U
  • 2026-01-14Form C filedC$5.0M
  • 2026-01-14Form C amendedC/A$5.0M

From SEC EDGAR, as filed. Issuer filing history.

Terminal Analysis

Investor

Terminal analysis for this offering

Terminal access unlocks issuer filing history and cross-platform comparisons for this offering.

Access full research

See what the terminal covers →

Questions About This Offering

What is BioXgen Holdings, Inc.?

BioXgen Holdings, Inc. is a $5,000,000 offering structured as a special purpose vehicle listed on DealMaker. The securities are offered under Regulation CF. Terms shown here are drawn from SEC filings and were captured by AltStreet on 2026-08-24. Figures are as disclosed at the time of the offering and are not updated for subsequent performance.

Who is the issuer of BioXgen Holdings, Inc.?

The offering relies on Regulation CF, which allows any investor to participate within annual limits.

When did BioXgen Holdings, Inc. launch and close?

The offering launched on 2026-01-14. It closed on 2026-05-15. AltStreet records its status as funding closed.

Is BioXgen Holdings, Inc. still open to investors?

AltStreet's record shows the offering as funding closed. AltStreet tracks this offering from SEC filings, last captured 2026-08-24. Offering status changes without a corresponding filing in many cases, so current availability should be confirmed directly with DealMaker before acting.

Related Offerings on DealMaker

Longevity Biotech offerings on other platforms

All DealMaker offerings →All longevity biotech offerings →

Sources & Related Research

AltStreet tracks this offering from primary sources and has no commercial relationship with the platform or issuer. Figures are as disclosed and may be incomplete; offering status changes without a corresponding filing in many cases. This page is informational and is not investment, legal, or tax advice, and it is not an offer to sell or a solicitation to buy any security.